236 related articles for article (PubMed ID: 29671181)
1. Hormone replacement therapy, mammographic density, and breast cancer risk: a cohort study.
Azam S; Lange T; Huynh S; Aro AR; von Euler-Chelpin M; Vejborg I; Tjønneland A; Lynge E; Andersen ZJ
Cancer Causes Control; 2018 Jun; 29(6):495-505. PubMed ID: 29671181
[TBL] [Abstract][Full Text] [Related]
2. Cigarette smoking and mammographic density in the Danish Diet, Cancer and Health cohort.
Jacobsen KK; Lynge E; Vejborg I; Tjønneland A; von Euler-Chelpin M; Andersen ZJ
Cancer Causes Control; 2016 Feb; 27(2):271-80. PubMed ID: 26645565
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and tumor characteristics of interval cancers by mammographic density.
Holm J; Humphreys K; Li J; Ploner A; Cheddad A; Eriksson M; Törnberg S; Hall P; Czene K
J Clin Oncol; 2015 Mar; 33(9):1030-7. PubMed ID: 25646195
[TBL] [Abstract][Full Text] [Related]
4. Influence of lifestyle factors on mammographic density in postmenopausal women.
Brand JS; Czene K; Eriksson L; Trinh T; Bhoo-Pathy N; Hall P; Celebioglu F
PLoS One; 2013; 8(12):e81876. PubMed ID: 24349146
[TBL] [Abstract][Full Text] [Related]
5. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy, percent mammographic density, and sensitivity of mammography.
Kavanagh AM; Cawson J; Byrnes GB; Giles GG; Marr G; Tong B; Gertig DM; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1060-4. PubMed ID: 15894653
[TBL] [Abstract][Full Text] [Related]
7. Digital versus screen-film mammography: impact of mammographic density and hormone therapy on breast cancer detection.
Chiarelli AM; Prummel MV; Muradali D; Shumak RS; Majpruz V; Brown P; Jiang H; Done SJ; Yaffe MJ
Breast Cancer Res Treat; 2015 Nov; 154(2):377-87. PubMed ID: 26518019
[TBL] [Abstract][Full Text] [Related]
8. Birth weight, childhood body mass index, and height in relation to mammographic density and breast cancer: a register-based cohort study.
Andersen ZJ; Baker JL; Bihrmann K; Vejborg I; Sørensen TI; Lynge E
Breast Cancer Res; 2014 Jan; 16(1):R4. PubMed ID: 24443815
[TBL] [Abstract][Full Text] [Related]
9. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography.
Carney PA; Miglioretti DL; Yankaskas BC; Kerlikowske K; Rosenberg R; Rutter CM; Geller BM; Abraham LA; Taplin SH; Dignan M; Cutter G; Ballard-Barbash R
Ann Intern Med; 2003 Feb; 138(3):168-75. PubMed ID: 12558355
[TBL] [Abstract][Full Text] [Related]
10. Case-control study of increased mammographic breast density response to hormone replacement therapy.
Vachon CM; Sellers TA; Vierkant RA; Wu FF; Brandt KR
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1382-8. PubMed ID: 12433715
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy and mammographic screening outcomes in Western Australia.
Crouchley K; Wylie E; Khong E
J Med Screen; 2006; 13(2):93-7. PubMed ID: 16792833
[TBL] [Abstract][Full Text] [Related]
12. Positive predictive values by mammographic density and screening mode in the Norwegian Breast Cancer Screening Program.
Moshina N; Ursin G; Roman M; Sebuødegård S; Hofvind S
Eur J Radiol; 2016 Jan; 85(1):248-254. PubMed ID: 26724673
[TBL] [Abstract][Full Text] [Related]
13. Mammographic density in birth cohorts of Danish women: a longitudinal study.
Hellmann SS; Lynge E; Schwartz W; Vejborg I; Njor SH
BMC Cancer; 2013 Sep; 13():409. PubMed ID: 24106754
[TBL] [Abstract][Full Text] [Related]
14. Is a dense mammographic parenchymal pattern a contraindication to hormonal replacement therapy?
Salminen TM; Saarenmaa IE; Heikkilä MM; Hakama M
Acta Oncol; 2000; 39(8):969-72. PubMed ID: 11207004
[TBL] [Abstract][Full Text] [Related]
15. Long-term exposure to air pollution and mammographic density in the Danish Diet, Cancer and Health cohort.
Huynh S; von Euler-Chelpin M; Raaschou-Nielsen O; Hertel O; Tjønneland A; Lynge E; Vejborg I; Andersen ZJ
Environ Health; 2015 Apr; 14():31. PubMed ID: 25879829
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.
Stahlberg C; Pedersen AT; Lynge E; Andersen ZJ; Keiding N; Hundrup YA; Obel EB; Ottesen B
Int J Cancer; 2004 May; 109(5):721-7. PubMed ID: 14999781
[TBL] [Abstract][Full Text] [Related]
17. Mammographic density changes in perimenopausal and postmenopausal women: is effect of hormone replacement therapy predictable?
Sterns EE; Zee B
Breast Cancer Res Treat; 2000 Jan; 59(2):125-32. PubMed ID: 10817347
[TBL] [Abstract][Full Text] [Related]
18. Effects of statin use on volumetric mammographic density: results from the KARMA study.
Skarping I; Brand JS; Hall P; Borgquist S
BMC Cancer; 2015 May; 15():435. PubMed ID: 26016855
[TBL] [Abstract][Full Text] [Related]
19. Do breast cancer risk factors modify the association between hormone therapy and mammographic breast density? (United States).
Aiello EJ; Buist DS; White E
Cancer Causes Control; 2006 Dec; 17(10):1227-35. PubMed ID: 17111253
[TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy and breast cancer: heterogeneous risks by race, weight, and breast density.
Hou N; Hong S; Wang W; Olopade OI; Dignam JJ; Huo D
J Natl Cancer Inst; 2013 Sep; 105(18):1365-72. PubMed ID: 24003037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]